Go Pro

Astera Labs, Inc. $ALAB Shares Sold by Algert Global LLC

Astera Labs logo with Technology background
Image from MarketBeat Media, LLC.

Key Points

  • Algert Global cut its Astera Labs position by 94.7% in the second quarter, selling 11,395 shares and retaining 642 shares worth approximately $310,000. Institutional investors still own 60.47% of the company.
  • Astera Labs insiders sold 419,244 shares worth $163.1 million over the past three months. The reported sales included transactions by COO Sanjay Gajendra and Director Stefan A. Dyckerhoff, including sales tied to tax obligations and a Rule 10b5-1 plan.
  • The company exceeded quarterly expectations, reporting $0.80 EPS and $392.4 million in revenue, up 104.5% year over year. Analysts maintain a consensus “Moderate Buy” rating with an average price target of $340.53.
  • Interested in Astera Labs? Here are five stocks we like better.

Algert Global LLC lowered its position in shares of Astera Labs, Inc. (NASDAQ:ALAB - Free Report) by 94.7% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 642 shares of the company's stock after selling 11,395 shares during the quarter. Algert Global LLC's holdings in Astera Labs were worth $310,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also made changes to their positions in the company. Eurizon Capital SGR S.p.A. purchased a new position in Astera Labs during the fourth quarter worth about $18,708,000. Swedbank AB grew its stake in shares of Astera Labs by 76.8% in the 4th quarter. Swedbank AB now owns 78,140 shares of the company's stock valued at $12,999,000 after buying an additional 33,940 shares during the period. Mitsubishi UFJ Morgan Stanley Securities Co. Ltd. purchased a new stake in shares of Astera Labs during the 4th quarter valued at approximately $499,000. Revere Asset Management Inc acquired a new position in Astera Labs in the fourth quarter valued at approximately $589,000. Finally, Banque Cantonale Vaudoise grew its position in Astera Labs by 85.9% in the first quarter. Banque Cantonale Vaudoise now owns 6,990 shares of the company's stock worth $766,000 after acquiring an additional 3,229 shares during the period. Hedge funds and other institutional investors own 60.47% of the company's stock.

Insider Buying and Selling

In other Astera Labs news, COO Sanjay Gajendra sold 90,630 shares of the business's stock in a transaction on Monday, August 17th. The shares were sold at an average price of $340.35, for a total value of $30,845,920.50. Following the completion of the transaction, the chief operating officer owned 1,119,038 shares in the company, valued at $380,864,583.30. The trade was a 7.49% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Stefan A. Dyckerhoff sold 8,994 shares of the company's stock in a transaction on Wednesday, July 1st. The stock was sold at an average price of $450.00, for a total value of $4,047,300.00. Following the sale, the director directly owned 4,631 shares in the company, valued at $2,083,950. This represents a 66.01% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 419,244 shares of company stock worth $163,135,169 over the last three months. 10.40% of the stock is owned by insiders.

Analysts Set New Price Targets

A number of equities analysts have recently weighed in on ALAB shares. Stifel Nicolaus increased their price target on Astera Labs from $260.00 to $460.00 and gave the stock a "buy" rating in a report on Wednesday, June 24th. TD Cowen reduced their price objective on shares of Astera Labs from $425.00 to $375.00 and set a "hold" rating on the stock in a report on Wednesday, August 5th. Barclays upped their target price on shares of Astera Labs from $200.00 to $325.00 and gave the company an "equal weight" rating in a research report on Monday, July 20th. Citigroup reaffirmed a "buy" rating on shares of Astera Labs in a research note on Wednesday, July 29th. Finally, Zacks Research upgraded shares of Astera Labs from a "hold" rating to a "strong-buy" rating in a report on Tuesday, August 11th. One research analyst has rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and eight have assigned a Hold rating to the stock. According to data from MarketBeat.com, Astera Labs currently has a consensus rating of "Moderate Buy" and a consensus target price of $340.53.

Read Our Latest Stock Analysis on ALAB

Astera Labs Stock Performance

Shares of ALAB opened at $296.98 on Tuesday. The stock has a market capitalization of $51.52 billion, a PE ratio of 147.02 and a beta of 3.84. Astera Labs, Inc. has a 1 year low of $97.89 and a 1 year high of $499.48. The company's 50-day simple moving average is $339.53 and its 200-day simple moving average is $250.89.

Astera Labs (NASDAQ:ALAB - Get Free Report) last announced its quarterly earnings data on Tuesday, August 4th. The company reported $0.80 earnings per share for the quarter, beating analysts' consensus estimates of $0.69 by $0.11. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The firm had revenue of $392.40 million during the quarter, compared to analysts' expectations of $360.85 million. During the same quarter in the previous year, the business posted $0.44 earnings per share. The business's quarterly revenue was up 104.5% compared to the same quarter last year. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, sell-side analysts predict that Astera Labs, Inc. will post 2.7 earnings per share for the current year.

About Astera Labs

(Free Report)

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company's product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.

See Also

Institutional Ownership by Quarter for Astera Labs (NASDAQ:ALAB)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Astera Labs Right Now?

Before you consider Astera Labs, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Astera Labs wasn't on the list.

While Astera Labs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best High-Yield Dividend Stocks for 2026 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines